US Stock MarketDetailed Quotes

MCRB Seres Therapeutics

Watchlist
  • 0.560
  • -0.024-4.16%
Close Apr 19 16:00 ET
  • 0.583
  • +0.023+4.14%
Post 19:59 ET
84.55MMarket Cap-629P/E (TTM)

Seres Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
1,672.24%126.33M
-93.44%64K
-91.00%310K
10,300.74%126.47M
-134.96%-522K
-95.08%7.13M
-88.24%975K
-97.28%3.44M
-76.90%1.22M
-73.89%1.49M
Operating revenue
1,672.24%126.33M
-93.44%64K
-91.00%310K
10,300.74%126.47M
-134.96%-522K
-95.08%7.13M
-88.24%975K
-97.28%3.44M
-76.90%1.22M
-73.89%1.49M
Cost of revenue
Gross profit
Operating expense
-7.61%234.31M
-42.86%39.59M
-23.71%47.72M
19.22%76.95M
22.36%70.05M
21.10%253.62M
20.02%69.28M
7.26%62.55M
20.85%64.54M
39.47%57.24M
Selling and administrative expenses
10.10%87.74M
-23.08%17.23M
8.73%19.99M
37.94%28.05M
21.00%22.47M
15.06%79.69M
9.26%22.4M
-6.03%18.38M
16.53%20.34M
58.17%18.57M
-General and administrative expense
10.10%87.74M
-23.08%17.23M
8.73%19.99M
37.94%28.05M
21.00%22.47M
15.06%79.69M
9.26%22.4M
-6.03%18.38M
16.53%20.34M
58.17%18.57M
Research and development costs
-15.65%145.86M
-41.92%26.85M
-34.47%28.25M
6.50%46.79M
10.90%43.97M
21.87%172.92M
25.76%46.22M
8.11%43.12M
22.20%43.94M
35.31%39.65M
Other operating expenses
-29.88%704K
-782.37%-4.49M
-149.38%-519K
677.12%2.11M
469.57%3.61M
157.97%1M
41.51%658K
193.26%1.05M
--271K
---976K
Operating profit
56.19%-107.98M
42.13%-39.53M
19.78%-47.41M
178.21%49.52M
-26.58%-70.57M
-282.20%-246.49M
-38.18%-68.31M
-186.40%-59.11M
-31.54%-63.33M
-57.82%-55.75M
Net non-operating interest income expense
-98.35%-5.88M
-341.63%-2.06M
-67.05%-1.44M
-32.10%-1.46M
-73.48%-916K
-7,305.00%-2.96M
-84.19%-466K
-459.74%-862K
-1,240.21%-1.11M
-295.56%-528K
Non-operating interest income
138.75%7.3M
39.39%1.97M
197.34%2.57M
336.96%1.73M
168.75%1.03M
6.55%3.06M
191.55%1.41M
46.61%865K
-52.35%395K
-60.25%384K
Non-operating interest expense
118.87%13.18M
114.31%4.03M
132.31%4.01M
112.33%3.19M
113.60%1.95M
106.87%6.02M
154.74%1.88M
132.12%1.73M
105.05%1.5M
31.03%912K
Other net income (expense)
119.01%134K
1,560.87%336K
3,127.27%999K
-397.04%-1.51M
189.86%310K
32.54%-705K
92.72%-23K
5.71%-33K
-6.67%-304K
15.65%-345K
Other non- operating income (expenses)
119.01%134K
1,560.87%336K
3,127.27%999K
-397.04%-1.51M
189.86%310K
32.54%-705K
92.72%-23K
5.71%-33K
-6.67%-304K
15.65%-345K
Income before tax
54.54%-113.72M
40.04%-41.25M
20.25%-47.85M
171.91%46.55M
-25.70%-71.17M
-281.46%-250.16M
-37.59%-68.8M
-187.96%-60M
-33.94%-64.74M
-59.66%-56.62M
Income tax
Net income
54.54%-113.72M
40.04%-41.25M
20.25%-47.85M
171.91%46.55M
-25.70%-71.17M
-281.46%-250.16M
-37.59%-68.8M
-187.96%-60M
-33.94%-64.74M
-59.66%-56.62M
Net income continuous Operations
54.54%-113.72M
40.04%-41.25M
20.25%-47.85M
171.91%46.55M
-25.70%-71.17M
-281.46%-250.16M
-37.59%-68.8M
-187.96%-60M
-33.94%-64.74M
-59.66%-56.62M
Minority interest income
Net income attributable to the parent company
54.54%-113.72M
40.04%-41.25M
20.25%-47.85M
171.91%46.55M
-25.70%-71.17M
-281.46%-250.16M
-37.59%-68.8M
-187.96%-60M
-33.94%-64.74M
-59.66%-56.62M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
54.54%-113.72M
40.04%-41.25M
20.25%-47.85M
171.91%46.55M
-25.70%-71.17M
-281.46%-250.16M
-37.59%-68.8M
-187.96%-60M
-33.94%-64.74M
-59.66%-56.62M
Basic earnings per share
61.47%-0.89
40.74%-0.32
24.49%-0.37
151.43%0.36
6.56%-0.57
-220.83%-2.31
1.82%-0.54
-166.22%-0.49
-32.08%-0.7
-56.41%-0.61
Diluted earnings per share
61.47%-0.89
40.74%-0.32
24.49%-0.37
151.43%0.36
6.56%-0.57
-220.83%-2.31
1.82%-0.54
-168.06%-0.49
-32.08%-0.7
-56.41%-0.61
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 1,672.24%126.33M-93.44%64K-91.00%310K10,300.74%126.47M-134.96%-522K-95.08%7.13M-88.24%975K-97.28%3.44M-76.90%1.22M-73.89%1.49M
Operating revenue 1,672.24%126.33M-93.44%64K-91.00%310K10,300.74%126.47M-134.96%-522K-95.08%7.13M-88.24%975K-97.28%3.44M-76.90%1.22M-73.89%1.49M
Cost of revenue
Gross profit
Operating expense -7.61%234.31M-42.86%39.59M-23.71%47.72M19.22%76.95M22.36%70.05M21.10%253.62M20.02%69.28M7.26%62.55M20.85%64.54M39.47%57.24M
Selling and administrative expenses 10.10%87.74M-23.08%17.23M8.73%19.99M37.94%28.05M21.00%22.47M15.06%79.69M9.26%22.4M-6.03%18.38M16.53%20.34M58.17%18.57M
-General and administrative expense 10.10%87.74M-23.08%17.23M8.73%19.99M37.94%28.05M21.00%22.47M15.06%79.69M9.26%22.4M-6.03%18.38M16.53%20.34M58.17%18.57M
Research and development costs -15.65%145.86M-41.92%26.85M-34.47%28.25M6.50%46.79M10.90%43.97M21.87%172.92M25.76%46.22M8.11%43.12M22.20%43.94M35.31%39.65M
Other operating expenses -29.88%704K-782.37%-4.49M-149.38%-519K677.12%2.11M469.57%3.61M157.97%1M41.51%658K193.26%1.05M--271K---976K
Operating profit 56.19%-107.98M42.13%-39.53M19.78%-47.41M178.21%49.52M-26.58%-70.57M-282.20%-246.49M-38.18%-68.31M-186.40%-59.11M-31.54%-63.33M-57.82%-55.75M
Net non-operating interest income expense -98.35%-5.88M-341.63%-2.06M-67.05%-1.44M-32.10%-1.46M-73.48%-916K-7,305.00%-2.96M-84.19%-466K-459.74%-862K-1,240.21%-1.11M-295.56%-528K
Non-operating interest income 138.75%7.3M39.39%1.97M197.34%2.57M336.96%1.73M168.75%1.03M6.55%3.06M191.55%1.41M46.61%865K-52.35%395K-60.25%384K
Non-operating interest expense 118.87%13.18M114.31%4.03M132.31%4.01M112.33%3.19M113.60%1.95M106.87%6.02M154.74%1.88M132.12%1.73M105.05%1.5M31.03%912K
Other net income (expense) 119.01%134K1,560.87%336K3,127.27%999K-397.04%-1.51M189.86%310K32.54%-705K92.72%-23K5.71%-33K-6.67%-304K15.65%-345K
Other non- operating income (expenses) 119.01%134K1,560.87%336K3,127.27%999K-397.04%-1.51M189.86%310K32.54%-705K92.72%-23K5.71%-33K-6.67%-304K15.65%-345K
Income before tax 54.54%-113.72M40.04%-41.25M20.25%-47.85M171.91%46.55M-25.70%-71.17M-281.46%-250.16M-37.59%-68.8M-187.96%-60M-33.94%-64.74M-59.66%-56.62M
Income tax
Net income 54.54%-113.72M40.04%-41.25M20.25%-47.85M171.91%46.55M-25.70%-71.17M-281.46%-250.16M-37.59%-68.8M-187.96%-60M-33.94%-64.74M-59.66%-56.62M
Net income continuous Operations 54.54%-113.72M40.04%-41.25M20.25%-47.85M171.91%46.55M-25.70%-71.17M-281.46%-250.16M-37.59%-68.8M-187.96%-60M-33.94%-64.74M-59.66%-56.62M
Minority interest income
Net income attributable to the parent company 54.54%-113.72M40.04%-41.25M20.25%-47.85M171.91%46.55M-25.70%-71.17M-281.46%-250.16M-37.59%-68.8M-187.96%-60M-33.94%-64.74M-59.66%-56.62M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 54.54%-113.72M40.04%-41.25M20.25%-47.85M171.91%46.55M-25.70%-71.17M-281.46%-250.16M-37.59%-68.8M-187.96%-60M-33.94%-64.74M-59.66%-56.62M
Basic earnings per share 61.47%-0.8940.74%-0.3224.49%-0.37151.43%0.366.56%-0.57-220.83%-2.311.82%-0.54-166.22%-0.49-32.08%-0.7-56.41%-0.61
Diluted earnings per share 61.47%-0.8940.74%-0.3224.49%-0.37151.43%0.366.56%-0.57-220.83%-2.311.82%-0.54-168.06%-0.49-32.08%-0.7-56.41%-0.61
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg